Cowen Prime Advisors LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

Back to all holdings Add to watchlist

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 26 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Cowen Prime Advisors LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q1 2022$462,000
-85.6%
332,197
-44.0%
0.19%
-82.3%
Q4 2021$3,215,000
-19.4%
593,133
-15.1%
1.09%
-26.3%
Q3 2021$3,989,000
+20.4%
698,533
+22.5%
1.48%
+23.5%
Q2 2021$3,314,000–570,333–1.20%–
 Download
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 6,966$7,0000.01%
TWO SIGMA SECURITIES, LLC 57,454$59,0000.00%
Virtu Financial LLC 13,127$14,0000.00%
UBS Group AG 26$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 60$00.00%
OSAIC HOLDINGS, INC. 13$00.00%
WELLS FARGO & COMPANY/MN 50$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 47,178$48,0000.00%
STATE STREET CORP 14,455$15,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders